KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,000 | -83.3% | 110 | -89.7% | 0.00% | -100.0% |
Q2 2019 | $6,000 | – | 1,068 | +1470.6% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 68 | -32.0% | 0.00% | – |
Q3 2015 | $1,000 | -80.0% | 100 | -50.0% | 0.00% | -100.0% |
Q2 2015 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $6,000 | +50.0% | 200 | +100.0% | 0.00% | +100.0% |
Q4 2014 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |